ELSIE, MI - January 05, 2026 - PRESSADVANTAGE - StayDry® has issued a guide that details approaches to identifying and ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...

ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

I’d back these 10 ASX shares in 2026 with a large investment to beat the market. Here’s why they’re such compelling buys ...

This year, the e-discovery landscape will likely be marked by the growing prominence of gen AI and court rulings paving the ...

The $100-and-up deals were done at 125 buildings, compared with the 2024 tally of 85, according to JLL’s year-end Analysis of ...

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...

Community members express concern over the New Year's Eve club shooting that injured the rising Dallas rapper, and they now ...

Teako sells 90% interests in five copper, zinc, gold and silver projects (Mykkelvika, Heimdalhaugen, Sivilvangen, Klasberget, ...